Soligenix Announces $1.5 Million NIH Small Business Innovation Research Award Advancing COVID-19 Vaccine Development
- Monday, December 28, 2020, 7:24
- PR Newswire
- Add a comment
PRINCETON, N.J., Dec. 28, 2020 /PRNewswire/ — Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the…
About the Author
admin has written 20652 stories on this site.